PPARGC1A and gallstones: Thus, it is plausible to speculate that peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC1α)-associated reduction of FXR activity could contribute to altered bile composition and gallstone formation through inhibition of BSEP and MDR3.